ERG and pulmonary fibrosis: The lungs of bleomycin/tamoxifen-treated ERG CKO mice, however, still exhibited elevated weight and hydroxyproline content at the same time point, demonstrating that, similarly to aged mice, loss of endothelial ERG in young mice initiated at day 14 impaired lung fibrosis resolution following bleomycin challenge.